These atlases can be used to identify the extent to which GPCR peptide ligand gene expression and GPCR/peptide signalling pathways are common to mouse and human islets, which will facilitate the translation of experimental results obtained using mouse islets and mouse models of metabolic disease to the human islet context. This evidence concerns the gene LGR6 and Other metabolic disease.